24 Jun 2021

Labeling Solutions Brochure

PDF 2.1 MB

This brochure gives an overview of common pharmaceutical and healthcare applications and the UPM Raflatac label solutions that meet these various needs. Every pharmaceutical packaging and labeling solution must comply with strict industry regulations. UPM Raflatac pharmaceutical label materials meet or exceed the following regulatory and safety requirements:

  • EMA (European Medicines Agency)/CVMP/205/04 Guideline on plastic immediate packaging materials 19 May 2005 
  • FDA (Food and Drug Administration, USA) Guidance on Container Closure Systems for Packaging Human Drugs and Biologics (1999) 
  • Compliance with 1907/2006/EC (REACH) 
  • European food contact regulations; Food Framework Regulation 1935/2004,plastics regulated by EU 10/2011 
  • FDA food contact compliance: FDA 21 CFR 175.105 and 175.125 for adhesives; FDA 21 CFR 176.170 and 176.180 for papers
  • Falsified Medicines Directive (2011/62/EU

Content provided by our supplier

UPM Raflatac

  • US
  • 2018
    On CPHI since
  • 1
  • 1000 - 4999
Company types

Other Content from UPM Raflatac ()